A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer

Development of resistance to gemcitabine is a major concern in bladder cancer therapy, and the mechanism remains unclear. Eg5 has been recently identified as an attractive target in cancer chemotherapy, so novel targeted chemotherapy with Eg5 inhibitor is expected to improve the anticancer effect in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Sun, Liang, Lu, Jiaju, Niu, Zhihong, Ding, Kejia, Bi, Dongbin, Liu, Shuai, Li, Jiamei, Wu, Fei, Zhang, Hui, Zhao, Zuohui, Ding, Sentai
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4675549/
https://ncbi.nlm.nih.gov/pubmed/26658059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0144484
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados